GLP-1/Glucagon Coagonism Restores Leptin Responsiveness in Obese Mice Chronically Maintained on an Obesogenic Diet
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
We recently reported restoration of leptin responsiveness in diet-induced obese (DIO) mice using a pharmacologically optimized, polyethylene-glycolated (PEG)-leptin analog in combination with exendin-4 or FGF21. However, the return of leptin action required discontinuation of high-fat diet (HFD) exposure. Here we assess whether a single peptide possessing balanced coagonism at the glucagon-like peptide 1 (GLP-1) and glucagon receptors can restore leptin responsiveness in DIO mice maintained on a HFD. DIO mice were treated with PEG-GLP-1/glucagon (30 nmol/kg every fourth day) to induce an ∼15% body weight loss, upon which they were randomized to continue PEG-GLP-1/glucagon therapy or reassigned to receive supplemental daily PEG-leptin (185 nmol/kg/day). The addition of PEG-leptin to PEG-GLP-1/glucagon resulted in an ∼18% greater weight loss as compared with PEG-GLP-1/glucagon alone and was accompanied by further decreases in food intake and improved glucose and lipid metabolism. The beneficial effect of PEG-leptin supplementation occurred after an initial body weight loss similar to what we previously reported following reduced dietary fat along with PEG-leptin and exendin-4 or FGF21 cotreatment. In summary, we report that GLP-1/glucagon coagonism restores leptin responsiveness in mice maintained on a HFD, thus emphasizing the translational value of this polypharmacotherapy for the treatment of obesity and diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Farooqi, I. S., Matarese, G., Lord, G. M., Keogh, J. M., Lawrence, E., Agwu, C., Sanna, V., Jebb, S. A., Perna, F., Fontana, S., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215693 · Cited by 1,105
Physiological response to long-term peripheral and central leptin infusion in lean and obese mice.
Halaas, J. L., Boozer, C., Blair-West, J., Fidahusein, N., Denton, D. A., & Friedman, J. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8878 · Cited by 1,033
A new glucagon and GLP-1 co-agonist eliminates obesity in rodents
Day, J. W., Ottaway, N., Patterson, J. T., Gelfanov, V., Smiley, D., Gidda, J., Findeisen, H., Bruemmer, D., Drucker, D. J., Chaudhary, N., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.209 · Cited by 641
Self-citationLicinio, J., Caglayan, S., Ozata, M., Yildiz, B. O., de Miranda, P. B., O'Kirwan, F., Whitby, R., Liang, L., Cohen, P., Bhasin, S., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308767101 · Cited by 505
Roth, J. D., Roland, B. L., Cole, R. L., Trevaskis, J. L., Weyer, C., Koda, J. E., Anderson, C. M., Parkes, D. G., & Baron, A. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706473105 · Cited by 436
Weekly Subcutaneous Pegylated Recombinant Native Human Leptin (PEG-OB) Administration in Obese Men
Hukshorn, C. J., Saris, W. H. M., Westerterp-Plantenga, M. S., Farid, A. R., Smith, F. J., & Campfield, L. A. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.11.6955 · Cited by 220
Müller, T. D., Sullivan, L. M., Habegger, K., Yi, C., Kabra, D., Grant, E., Ottaway, N., Krishna, R., Holland, J., Hembree, J., et al. (2012) · Journal of Peptide Science · doi:10.1002/psc.2408 · Cited by 156 · cited 6×
“The observation that coadministration of PEG-leptin with exendin-4 or FGF21 failed to restore leptin responsiveness when mice were maintained on a HFD (10) correlates with recent reports demonstrating that leptin resistance occurs immediately following HFD exposure and prior to an increase in adiposity (14,18,19,22,23…”
BackgroundMethodResultInfluentialSelf-citation
Research works printed but not linked: 16
- Zhang, 1994, Positional cloning of the mouse obese gene and its human homologue, Nature, 372, 425, 10.1038/372425a0 · DOI · Paper page
- Halaas, 1995, Weight-reducing effects of the plasma protein encoded by the obese gene, Science, 269, 543, 10.1126/science.7624777 · DOI · Paper page
- Heymsfield, 1999, Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial, JAMA, 282, 1568, 10.1001/jama.282.16.1568 · DOI · Paper page
- Scarpace, 2009, Leptin resistance: a prediposing factor for diet-induced obesity, Am J Physiol Regul Integr Comp Physiol, 296, R493, 10.1152/ajpregu.90669.2008 · DOI · Paper page
- Trevaskis, 2010, Interaction of leptin and amylin in the long-term maintenance of weight loss in diet-induced obese rats, Obesity (Silver Spring), 18, 21, 10.1038/oby.2009.187 · DOI · Paper page
- Sadry, 2013, Emerging combinatorial hormone therapies for the treatment of obesity and T2DM, Nat Rev Endocrinol, 9, 425, 10.1038/nrendo.2013.47 · DOI · Paper page
- Coppari, 2012, Leptin revisited: its mechanism of action and potential for treating diabetes, Nat Rev Drug Discov, 11, 692, 10.1038/nrd3757 · DOI · Paper page
- Vasselli, 2013, Dietary components in the development of leptin resistance, Adv Nutr, 4, 164, 10.3945/an.112.003152 · DOI
- Vasselli, 2012, The role of dietary components in leptin resistance, Adv Nutr, 3, 736, 10.3945/an.112.002659 · DOI
- Vasselli, 2008, Fructose-induced leptin resistance: discovery of an unsuspected form of the phenomenon and its significance. Focus on “Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high-fat feeding,” by Shapiro et al, Am J Physiol Regul Integr Comp Physiol, 295, R1365, 10.1152/ajpregu.90674.2008 · DOI
- Vasselli, 2001, Behavioral and biological determinants of leptin resistance, Appetite, 37, 115, 10.1006/appe.2001.0418 · DOI
- Thaler, 2012, Obesity is associated with hypothalamic injury in rodents and humans, J Clin Invest, 122, 153, 10.1172/JCI59660 · DOI · Paper page
- Wang, 2001, Overfeeding rapidly induces leptin and insulin resistance, Diabetes, 50, 2786, 10.2337/diabetes.50.12.2786 · DOI · Paper page
- Beiroa, 2013, Heterozygous deficiency of endoglin decreases insulin and hepatic triglyceride levels during high fat diet, PLoS ONE, 8, e54591, 10.1371/journal.pone.0054591 · DOI
- Banks, 2004, Triglycerides induce leptin resistance at the blood-brain barrier, Diabetes, 53, 1253, 10.2337/diabetes.53.5.1253 · DOI · Paper page
- Shapiro, 2008, Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high-fat feeding, Am J Physiol Regul Integr Comp Physiol, 295, R1370, 10.1152/ajpregu.00195.2008 · DOI · Paper page
Cited by
Anti-obesity drug discovery: advances and challenges
Müller, T. D., Blüher, M., Tschöp, M. H., & DiMarchi, R. D. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00337-8 · Cited by 1,021
Self-citationLeptin and the endocrine control of energy balance
Friedman, J. M. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0095-y · Cited by 661
A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents
Finan, B., Yang, B., Ottaway, N., Smiley, D. L., Ma, T., Clemmensen, C., Chabenne, J., Zhang, L., Habegger, K. M., Fischer, K., et al. (2015) · Nature Medicine · doi:10.1038/nm.3761 · Cited by 645
Self-citationLeptin, Obesity, and Leptin Resistance: Where Are We 25 Years Later
Izquierdo, A. G., Crujeiras, A. B., Casanueva, F. F., & Carreira, M. C. (2019) · Nutrients · doi:10.3390/nu11112704 · Cited by 525
“It is noteworthy that in some of these studies, the loss of body weight was found to be insufficient to regain sensitivity to leptin, thus indicating the need to use combined strategies with two or more hormones to exert significant and lasting effects on weight loss [35,58].”
BackgroundThe New Biology and Pharmacology of Glucagon
Müller, T. D., Finan, B., Clemmensen, C., DiMarchi, R. D., & Tschöp, M. H. (2017) · Physiological Reviews · doi:10.1152/physrev.00025.2016 · Cited by 419
“A provocative preclinical observation was that GLP-1/glucagon coagonism restores leptin sensitivity in otherwise leptin-resistant DIO mice, even under persistent exposure to an extremely high-fat, high-sugar diet comprising 58% kcal fat (111).”
BackgroundSelf-citation
Metadata
- Authors
- Clemmensen, C., Chabenne, J., Finan, B., Sullivan, L., Fischer, K., Küchler, D., Sehrer, L., Ograjsek, T., Hofmann, S. M., Schriever, S. C., Pfluger, P. T., Pinkstaff, J., Tschöp, M. H., DiMarchi, R., & Müller, T. D.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2014-03-13
- Volume
- 63
- Issue
- 4
- Pages
- 1422-1427
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2041738999
- Cited by
- 136
- References
- 7
- FWCI
- 5.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.